Interaction Between Blood Vasculatures and Lymphatic Vasculatures During Inflammation

References

• Singh N, Baby D, Rajguru J, et al. Inflammation and cancer. Ann Afr Med. 2019;18(3):121–126. doi:10.4103/aam.aam_56_18
   PubMed Web of Science ®Google Scholar
• Furman D, Campisi J, Verdin E, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822–1832. doi:10.1038/s41591-019-0675-0
   PubMed Web of Science ®Google Scholar
• Newton K, Dixit VM, Kayagaki N. Dying cells fan the flames of inflammation. Science. 2021;374(6571):1076–1080. doi:10.1126/science.abi5934
   PubMed Web of Science ®Google Scholar
• Shi X, Seidle KA, Simms KJ, et al. Endothelial progenitor cells in the host defense response. Pharmacol Ther. 2023;241:108315. doi:10.1016/j.pharmthera.2022.108315
   PubMed Web of Science ®Google Scholar
• Lee HJ, Hong YJ, Kim M. Angiogenesis in chronic inflammatory skin disorders. Int J Mol Sci. 2021;22:12035.
   PubMed Web of Science ®Google Scholar
• Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development. Cell. 2019;176(6):1248–1264. doi:10.1016/j.cell.2019.01.021
   PubMed Web of Science ®Google Scholar
• Ling M, Lai X, Quan L, et al. Knockdown of VEGFB/VEGFR1 signaling promotes white adipose tissue browning and skeletal muscle development. Int J Mol Sci. 2022;23(14):7524. doi:10.3390/ijms23147524
   PubMed Web of Science ®Google Scholar
• Wang R, Yang M, Jiang L, Huang M. Role of angiopoietin-tie axis in vascular and lymphatic systems and therapeutic interventions. Pharmacol Res. 2022;182:106331. doi:10.1016/j.phrs.2022.106331
   PubMed Web of Science ®Google Scholar
• Secker GA, Harvey NL. VEGFR signaling during lymphatic vascular development: from progenitor cells to functional vessels. Dev Dyn. 2015;244(3):323–331. doi:10.1002/dvdy.24227
   PubMed Web of Science ®Google Scholar
• Wang X, Zhao J, Qin L. VEGF-C mediated enhancement of lymphatic drainage reduces intestinal inflammation by regulating IL-9/IL-17 balance and improving gut microbiota in experimental chronic colitis. Am J Transl Res. 2017;9(11):4772–4784.
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Miyazaki A. Hypercholesterolemia and lymphatic defects: the chicken or the egg?. Front Cardiovasc Med. 2021;8:701229. doi:10.3389/fcvm.2021.701229
   PubMed Web of Science ®Google Scholar
• Sammarco G, Varricchi G, Ferraro V, et al. Mast cells, angiogenesis and lymphangiogenesis in human gastric cancer. Int J Mol Sci. 2019;20(9):2106. doi:10.3390/ijms20092106
   PubMed Web of Science ®Google Scholar
• Wang XL, Zhao J, Qin L, Qiao M. Promoting inflammatory lymphangiogenesis by vascular endothelial growth factor-C (VEGF-C) aggravated intestinal inflammation in mice with experimental acute colitis. Braz J Med Biol Res. 2016;49(5):e4738. doi:10.1590/1414-431x20154738
   PubMed Web of Science ®Google Scholar
• D’Alessio S, Correale C, Tacconi C, et al. VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease. J Clin Invest. 2014;124(9):3863–3878. doi:10.1172/JCI72189
   PubMed Web of Science ®Google Scholar
• Li CZ, Jiang X-J, Lin B, et al. RIP1 regulates TNF-α-mediated lymphangiogenesis and lymphatic metastasis in gallbladder cancer by modulating the NF-κB-VEGF-C pathway. Onco Targets Ther. 2018;11:2875–2890. doi:10.2147/OTT.S159026
   PubMed Web of Science ®Google Scholar
• Tammela T, Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell. 2010;140(4):460–476. doi:10.1016/j.cell.2010.01.045
   PubMed Web of Science ®Google Scholar
• Immormino RM, Jania CM, Tilley SL, Moran TP. Neuropilin-2 regulates airway inflammation in a neutrophilic asthma model. Immun Inflamm Dis. 2022;10(3):e575. doi:10.1002/iid3.575
   PubMed Web of Science ®Google Scholar
• Islam R, Mishra J, Bodas S, et al. Role of Neuropilin-2-mediated signaling axis in cancer progression and therapy resistance. Cancer Metastasis Rev. 2022;41(3):771–787. doi:10.1007/s10555-022-10048-0
   PubMed Web of Science ®Google Scholar
• Mumprecht V, Detmar M. Lymphangiogenesis and cancer metastasis. J Cell Mol Med. 2009;13(8a):1405–1416. doi:10.1111/j.1582-4934.2009.00834.x
   PubMed Web of Science ®Google Scholar
• Huggenberger R, Detmar M. The cutaneous vascular system in chronic skin inflammation. J Invest Dermatol Symp Proc. 2011;15(1):24–32. doi:10.1038/jidsymp.2011.5
   PubMedGoogle Scholar
• Bowlin A, Roys H, Wanjala H, et al. Hypoxia-inducible factor signaling in macrophages promotes lymphangiogenesis in leishmania major infection. Infect Immun. 2021;89(8):e0012421. doi:10.1128/IAI.00124-21
   PubMed Web of Science ®Google Scholar
• Xie X, Wang Y, Xia Y, Mao Y. Overexpressed vascular endothelial growth factor in adipose derived stem cells attenuates fibroblasts and skin injuries by ultraviolet radiation. Biosci Rep. 2019;39(7). doi:10.1042/BSR20190433
   Google Scholar
• He Y, Kim J, Tacconi C, et al. Mediators of capillary-to-venule conversion in the chronic inflammatory skin disease psoriasis. J Invest Dermatol. 2022;142(12):3313–3326.e13. doi:10.1016/j.jid.2022.05.1089
   PubMed Web of Science ®Google Scholar
• Rodrigues-Braz D, Zhao M, Yesilirmak N, et al. Cutaneous and ocular rosacea: common and specific physiopathogenic mechanisms and study models. Mol Vis. 2021;27:323–353.
   PubMed Web of Science ®Google Scholar
• Stinco G, Buligan C, Maione V, Valent F, Patrone P. Videocapillaroscopic findings in the microcirculation of the psoriatic plaque during etanercept therapy. Clin Exp Dermatol. 2013;38(6):633–637. doi:10.1111/ced.12036
   PubMed Web of Science ®Google Scholar
• Micali G, Lacarrubba F, Musumeci ML, Massimino D, Nasca MR. Cutaneous vascular patterns in psoriasis. Int J Dermatol. 2010;49(3):249–256. doi:10.1111/j.1365-4632.2009.04287.x
   PubMed Web of Science ®Google Scholar
• Luengas‐Martinez A, Paus R, Young HS. Antivascular endothelial growth factor-a therapy: a novel personalized treatment approach for psoriasis. Br J Dermatol. 2022;186(5):782–791. doi:10.1111/bjd.20940
   PubMed Web of Science ®Google Scholar
• Schonthaler HB, Huggenberger R, Wculek SK, Detmar M, Wagner EF. Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis. Proc Natl Acad Sci U S A. 2009;106(50):21264–21269. doi:10.1073/pnas.0907550106
   PubMed Web of Science ®Google Scholar
• Meier TO, Kovacicova L, Huggenberger R, et al. Increased permeability of cutaneous lymphatic capillaries and enhanced blood flow in psoriatic plaques. Dermatology. 2013;227(2):118–125. doi:10.1159/000351878
   PubMed Web of Science ®Google Scholar
• Granata F, Frattini A, Loffredo S, et al. Production of vascular endothelial growth factors from human lung macrophages induced by group IIA and group X secreted phospholipases A2. J Immunol. 2010;184(9):5232–5241. doi:10.4049/jimmunol.0902501
   PubMed Web of Science ®Google Scholar
• Schwager S, Detmar M. Inflammation and lymphatic function. Front Immunol. 2019;10:308. doi:10.3389/fimmu.2019.00308
   PubMedGoogle Scholar
• Moustou AE, Alexandrou P, Stratigos AJ, et al. Expression of lymphatic markers and lymphatic growth factors in psoriasis before and after anti-TNF treatment. An Bras Dermatol. 2014;89(6):891–897. doi:10.1590/abd1806-4841.20143210
   PubMed Web of Science ®Google Scholar
• Syed SN, Raue R, Weigert A, von Knethen A, Brune B. Macrophage S1PR1 signaling alters angiogenesis and lymphangiogenesis during skin inflammation. Cells. 2019;8(8):785. doi:10.3390/cells8080785
   PubMed Web of Science ®Google Scholar
• Zheng Z, Zeng Y-Z, Ren K, et al. S1P promotes inflammation-induced tube formation by HLECs via the S1PR1/NF-κB pathway. Int Immunopharmacol. 2019;66:224–235. doi:10.1016/j.intimp.2018.11.032
   PubMed Web of Science ®Google Scholar
• Wang J, Liu L, Sun X-Y, et al. Evidence and potential mechanism of action of lithospermum erythrorhizon and its active components for psoriasis. Front Pharmacol. 2022;13:781850. doi:10.3389/fphar.2022.781850
   PubMed Web of Science ®Google Scholar
• Ambati BK, Nozaki M, Singh N, et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature. 2006;443(7114):993–997. doi:10.1038/nature05249
   PubMed Web of Science ®Google Scholar
• Azar DT. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American ophthalmological society thesis). Trans Am Ophthalmol Soc. 2006;104:264–302.
   PubMedGoogle Scholar
• Albuquerque RJC, Hayashi T, Cho WG, et al. Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med. 2009;15(9):1023–1030. doi:10.1038/nm.2018
   PubMed Web of Science ®Google Scholar
• Ceci C, Atzori MG, Lacal PM, Graziani G. Role of VEGFs/VEGFR-1 signaling and its inhibition in modulating tumor invasion: experimental evidence in different metastatic cancer models. Int J Mol Sci. 2020;21(4):1388. doi:10.3390/ijms21041388
   PubMed Web of Science ®Google Scholar
• Penn JS, Madan A, Caldwell RB, et al. Vascular endothelial growth factor in eye disease. Prog Retin Eye Res. 2008;27(4):331–371. doi:10.1016/j.preteyeres.2008.05.001
   PubMed Web of Science ®Google Scholar
• Nicholas MP, Mysore N. Corneal neovascularization. Exp Eye Res. 2021;202:108363. doi:10.1016/j.exer.2020.108363
   PubMed Web of Science ®Google Scholar
• Lee HK, Lee SM, Lee DI. Corneal lymphangiogenesis: current pathophysiological understandings and its functional role in ocular surface disease. Int J Mol Sci. 2021;22:11628.
   PubMed Web of Science ®Google Scholar
• Chung E-S, Saban DR, Chauhan SK, Dana R. Regulation of blood vessel versus lymphatic vessel growth in the cornea. Invest Ophthalmol Visual Sci. 2009;50(4):1613–1618. doi:10.1167/iovs.08-2212
   PubMed Web of Science ®Google Scholar
• Martinez NE, Sato F, Kawai E, et al. Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis. Future Virol. 2012;7:593–608. doi:10.2217/fvl.12.44
   PubMed Web of Science ®Google Scholar
• Povoa TF, Alves AMB, Oliveira CAB, et al. The pathology of severe dengue in multiple organs of human fatal cases: histopathology, ultrastructure and virus replication. PLoS One. 2014;9(4):e83386. doi:10.1371/journal.pone.0083386
   PubMed Web of Science ®Google Scholar
• Saggioro FP, Rossi M, Duarte M, et al. Hantavirus infection induces a typical myocarditis that may be responsible for myocardial depression and shock in hantavirus pulmonary syndrome. J Infect Dis. 2007;195(10):1541–1549. doi:10.1086/513874
   PubMed Web of Science ®Google Scholar
• Ino T, Kishiro M, Okubo M, et al. Late, persistent expressions of ICAM-1 and VCAM-1 on myocardial tissue in children with lymphocytic myocarditis. Cardiovasc Res. 1997;34(2):323–328. doi:10.1016/S0008-6363(97)00002-3
   PubMed Web of Science ®Google Scholar
• Benvenuti LA, Higuchi ML, Reis MM. Upregulation of adhesion molecules and class I HLA in the myocardium of chronic chagasic cardiomyopathy and heart allograft rejection, but not in dilated cardiomyopathy. Cardiovasc Pathol. 2000;9(2):111–117. doi:10.1016/S1054-8807(00)00027-2
   PubMed Web of Science ®Google Scholar
• Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation. 1999;99(8):1091–1100. doi:10.1161/01.CIR.99.8.1091
   PubMed Web of Science ®Google Scholar
• Woudstra L, Juffermans LJM, van Rossum AC, Niessen HWM, Krijnen PAJ. Infectious myocarditis: the role of the cardiac vasculature. Heart Fail Rev. 2018;23(4):583–595. doi:10.1007/s10741-018-9688-x
   PubMed Web of Science ®Google Scholar
• Zagrosek A, Wassmuth R, Abdel-Aty H, et al. Relation between myocardial edema and myocardial mass during the acute and convalescent phase of myocarditis – a CMR study. J Cardiovasc Magn Reson. 2008;10(1):19. doi:10.1186/1532-429X-10-19
   PubMedGoogle Scholar
• Shimada T, Noguchi T, Takita K, Kitamura H, Nakamura M. Morphology of lymphatics of the mammalian heart with special reference to the architecture and distribution of the subepicardial lymphatic system. Acta Anat. 1989;136(1):16–20. doi:10.1159/000146791
   PubMedGoogle Scholar
• Zhang L, Han B, Liu H, et al. Circular RNA circACSL1 aggravated myocardial inflammation and myocardial injury by sponging miR-8055 and regulating MAPK14 expression. Cell Death Dis. 2021;12(5):487. doi:10.1038/s41419-021-03777-7
   PubMed Web of Science ®Google Scholar
• Aldrich MB, Sevick-Muraca EM. Cytokines are systemic effectors of lymphatic function in acute inflammation. Cytokine. 2013;64(1):362–369. doi:10.1016/j.cyto.2013.05.015
   PubMed Web of Science ®Google Scholar
• Al-Kofahi M, Omura S, Tsunoda I, et al. IL-1β reduces cardiac lymphatic muscle contraction via COX-2 and PGE2 induction: potential role in myocarditis. Biomed Pharmacother. 2018;107:1591–1600. doi:10.1016/j.biopha.2018.08.004
   PubMed Web of Science ®Google Scholar
• Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in toll-like receptor-mediated neuronal injury. Glia. 2010;58(3):253–263. doi:10.1002/glia.20928
   PubMed Web of Science ®Google Scholar
• Lu S-Z, Wu Y, Guo Y-S, et al. Inhibition of astrocytic DRD2 suppresses CNS inflammation in an animal model of multiple sclerosis. J Exp Med. 2022;219(9). doi:10.1084/jem.20210998
   Web of Science ®Google Scholar
• Iliff JJ, Nedergaard M. Is there a cerebral lymphatic system? Stroke. 2013;44(6_suppl_1):S93–S95. doi:10.1161/STROKEAHA.112.678698
   PubMed Web of Science ®Google Scholar
• Aspelund A, Antila S, Proulx ST, et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med. 2015;212(7):991–999. doi:10.1084/jem.20142290
   PubMed Web of Science ®Google Scholar
• Wu F, Liu L, Zhou H. Endothelial cell activation in central nervous system inflammation. J Leukoc Biol. 2017;101(5):1119–1132. doi:10.1189/jlb.3RU0816-352RR
   PubMed Web of Science ®Google Scholar
• Davidson SM. Endothelial mitochondria and heart disease. Cardiovasc Res. 2010;88(1):58–66. doi:10.1093/cvr/cvq195
   PubMed Web of Science ®Google Scholar
• Li X, Qi L, Yang D, et al. Meningeal lymphatic vessels mediate neurotropic viral drainage from the central nervous system. Nat Neurosci. 2022;25(5):577–587. doi:10.1038/s41593-022-01063-z
   PubMed Web of Science ®Google Scholar
• Louveau A, Smirnov I, Keyes TJ, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523(7560):337–341. doi:10.1038/nature14432
   PubMed Web of Science ®Google Scholar
• Hogan BM, Bower NI. Lymphatics and the brain: it’s time to go fishing. Circ Res. 2021;128(1):59–61. doi:10.1161/CIRCRESAHA.120.318496
   PubMed Web of Science ®Google Scholar
• DeSesso JM, Jacobson CF. Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats. Food Chem Toxicol. 2001;39(3):209–228. doi:10.1016/S0278-6915(00)00136-8
   PubMed Web of Science ®Google Scholar
• Zhang F, Zarkada G, Han J, et al. Lacteal junction zippering protects against diet-induced obesity. Science. 2018;361(6402):599–603. doi:10.1126/science.aap9331
   PubMed Web of Science ®Google Scholar
• D’Alessio S, Tacconi C, Fiocchi C, Danese S. Advances in therapeutic interventions targeting the vascular and lymphatic endothelium in inflammatory bowel disease. Curr Opin Gastroenterol. 2013;29(6):608–613. doi:10.1097/MOG.0b013e328365d37c
   PubMed Web of Science ®Google Scholar
• Verstockt B, Vetrano S, Salas A, et al. Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2022;19(6):351–366. doi:10.1038/s41575-021-00574-7
   PubMed Web of Science ®Google Scholar
• Dai B, Hackney JA, Ichikawa R, et al. Dual targeting of lymphocyte homing and retention through α4β7 and αEβ7 inhibition in inflammatory bowel disease. Cell Rep Med. 2021;2(8):100381. doi:10.1016/j.xcrm.2021.100381
   PubMedGoogle Scholar
• Martin-Rodriguez O, Gauthier T, Bonnefoy F, et al. Pro-resolving factors released by macrophages after efferocytosis promote mucosal wound healing in inflammatory bowel disease. Front Immunol. 2021;12:754475. doi:10.3389/fimmu.2021.754475
   PubMed Web of Science ®Google Scholar
• Zhang L, Ocansey DK, Liu L, et al. Implications of lymphatic alterations in the pathogenesis and treatment of inflammatory bowel disease. Biomed Pharmacother. 2021;140:111752. doi:10.1016/j.biopha.2021.111752
   PubMed Web of Science ®Google Scholar
• Hokari R, Tomioka A. The role of lymphatics in intestinal inflammation. Inflamm Regen. 2021;41(1):25. doi:10.1186/s41232-021-00175-6
   PubMed Web of Science ®Google Scholar
• Sato H, Higashiyama M, Hozumi H, et al. Platelet interaction with lymphatics aggravates intestinal inflammation by suppressing lymphangiogenesis. Am J Physiol Gastrointest Liver Physiol. 2016;311(2):G276–G285. doi:10.1152/ajpgi.00455.2015
   PubMed Web of Science ®Google Scholar
• Lee AS, Hur HJ, Sung MJ. The effect of artemisinin on inflammation-associated lymphangiogenesis in experimental acute colitis. Int J Mol Sci. 2020;21:8068.
   PubMed Web of Science ®Google Scholar
• Solorzano E, Alejo AL, Ball HC, et al. Osteopathy in complex lymphatic anomalies. Int J Mol Sci. 2022;23(15):8258. doi:10.3390/ijms23158258
   PubMed Web of Science ®Google Scholar
• Chen J, Sivan U, Tan SL, et al. High-resolution 3D imaging uncovers organ-specific vascular control of tissue aging. Sci Adv. 2021;7:eabd7819.
   PubMed Web of Science ®Google Scholar
• Biswas L, Chen J, De Angelis J, et al. Lymphatic vessels in bone support regeneration after injury. Cell. 2023;186(2):382–397.e324. doi:10.1016/j.cell.2022.12.031
   PubMed Web of Science ®Google Scholar
• Stucker S, Chen J, Watt FE, Kusumbe AP. Bone angiogenesis and vascular niche remodeling in stress, aging, and diseases. Front Cell Dev Biol. 2020;8:602269. doi:10.3389/fcell.2020.602269
   PubMed Web of Science ®Google Scholar
• Klotz L, Norman S, Vieira JM, et al. Cardiac lymphatics are heterogeneous in origin and respond to injury. Nature. 2015;522(7554):62–67. doi:10.1038/nature14483
   PubMed Web of Science ®Google Scholar
• Da Mesquita S, Louveau A, Vaccari A, et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease. Nature. 2018;560(7717):185–191. doi:10.1038/s41586-018-0368-8
   PubMed Web of Science ®Google Scholar
• Lopez Gelston CA, Balasubbramanian D, Abouelkheir GR, et al. Enhancing renal lymphatic expansion prevents hypertension in mice. Circ Res. 2018;122(8):1094–1101. doi:10.1161/CIRCRESAHA.118.312765
   PubMed Web of Science ®Google Scholar
• Wang H, Chen Y, Li W, et al. Effect of VEGFC on lymph flow and inflammation-induced alveolar bone loss. J Pathol. 2020;251(3):323–335. doi:10.1002/path.5456
   PubMed Web of Science ®Google Scholar
• Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):762–774. doi:10.1001/jama.2016.0288
   PubMed Web of Science ®Google Scholar
• Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):775–787. doi:10.1001/jama.2016.0289
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Mempel TR, Henrickson SE, Von Andrian UH. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature. 2004;427(6970):154–159. doi:10.1038/nature02238
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang H-W, Mei H-X, et al. MCTR1 enhances the resolution of lipopolysaccharide-induced lung injury through STAT6-mediated resident M2 alveolar macrophage polarization in mice. J Cell Mol Med. 2020;24(17):9646–9657. doi:10.1111/jcmm.15481
   PubMed Web of Science ®Google Scholar